Hangzhou Testsea Biotechnology Co.,Ltd

Hangzhou Testsea Biotechnology Co.,Ltd, founded in 2015, is dedicated to the pursuit of human and global health with the slogan "Protect health, protect you". The company specializes in creating innovative technologies for the development of raw materials for diagnostic use, offering a range of diagnostic solutions including rapid diagnostic tests (RDTs), fluorescent immuno-diagnostic tests, ELISA, molecular diagnostic tests (MDx), and clinical chemistry. With a focus on in-house development of monoclonal antibodies and recombinant antigens, Hangzhou Testsea Biotechnology also possesses patented technologies, such as fluorescent immuno-diagnostics, which are expected to be pivotal in the future of in vitro diagnostics (IVD). The company's facility is certified with GMP, ISO9001, and ISO13458, and holds CE FDA approval, positioning the company for global expansion and collaboration. The dedication to research and development is evident in Hangzhou Testsea Biotechnology's accumulation of 1 software copyright and 50 authorized patents, including 4 invention patents. The company's commitment to innovation is reinforced by its workforce of more than 300 employees and an annual output of 300 million people, operating within a business area of 56,000 square meters. Hangzhou Testsea Biotechnology upholds the values of "integrity, quality, and responsibility", striving to develop high-quality diagnostic raw materials to contribute to the cause of human health. As a company committed to a healthy world, they are dedicated to promoting high-quality diagnostic products for the accurate diagnosis of all human diseases. With an emphasis on serving the society, Hangzhou Testsea Biotechnology is poised to make strides in the field of biotechnology, manufacturing, and medical devices.